1x95: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1x95.gif|left|200px]] | [[Image:1x95.gif|left|200px]] | ||
'''solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug''' | {{Structure | ||
|PDB= 1x95 |SIZE=350|CAPTION= <scene name='initialview01'>1x95</scene> | |||
|SITE= | |||
|LIGAND= <scene name='pdbligand=XR2:1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL)-12-OXO-2,11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL]PHENAZIN-10-IUM'>XR2</scene> | |||
|ACTIVITY= | |||
|GENE= | |||
}} | |||
'''solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug''' | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
1X95 is a [ | 1X95 is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X95 OCA]. | ||
==Reference== | ==Reference== | ||
Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug., Dai J, Punchihewa C, Mistry P, Ooi AT, Yang D, J Biol Chem. 2004 Oct 29;279(44):46096-103. Epub 2004 Aug 17. PMID:[http:// | Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug., Dai J, Punchihewa C, Mistry P, Ooi AT, Yang D, J Biol Chem. 2004 Oct 29;279(44):46096-103. Epub 2004 Aug 17. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15317822 15317822] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Dai, J.]] | [[Category: Dai, J.]] | ||
Line 26: | Line 35: | ||
[[Category: transcription inhibition]] | [[Category: transcription inhibition]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:06:39 2008'' |